AI Crafts Caffeine Safety Switch for Cell Therapies
Researchers at Texas A&M have developed a molecular switch called CODS that uses caffeine to control engineered cells by triggering protein dissociation. This AI-designed system acts as a 'brake' for gene and cell therapies, allowing scientists to pause or reset cellular activity on demand.
Why it matters
This technology provides a safer, more precise way to manage advanced medical treatments, potentially reducing side effects by allowing clinicians to deactivate therapeutic cells when necessary.
For many of us, a warm cup of coffee is how we start our day. For Texas A&M Health researchers, it may also offer a new way to control engineered cells in future medicines.
The article is a straightforward report on scientific research findings without political framing or subjective commentary.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in